Instead of laying in bed with the lovely Jimmylegs this Saturday morning (lucky man!) there is some detective work that needs to be undertaken.
Rituxan (which depletes B cells and in my modest view shows real promise as an MS treatment (don't get scared off by the "it might kill you brigade" - we're all going to die of something)) is in trial for PPMS (Phase III) and RRMS (Phase II). Rituxan is a joint effort from Biogen and Genentech.
Some months ago I saw that Genentech was working on a next generation B cell depleting drug, Anti-CD20. I looked on the company's website today and saw that an Anti-CD20 Phase II for RR MS and
a Phase III for RR MS are planned. There is mention of some dispute with Biogen (no doubt Harry Z is behind this!)
See link attached. Not sure how this affects your list of treaments?
http://www.gene.com/gene/pipeline/statu ... anti-cd20/